Our milestones: the birth of a new prostate cancer drug

23 Sep 2015
Cancer Research UK

In the latest in Our milestones, we look back to the 1990s, and to our ‘first-in-man’ trial of prostate cancer drug abiraterone – a vital step in the drug’s development that set the scene for its progression through to routine use on the NHS.

Please click here to read the 'Cancer Research UK' press release in full